SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending due to significant selling pressure, attributed to the expiration of a lock-up period releasing a large number of shares. The community is actively discussing the heavy selling at the $12 mark and debating whether this represents a buying opportunity or a sign of further decline. Comparisons to competitor Robinhood ($HOOD) and speculation about a potential short squeeze are also prominent talking points.

Above Food Ingredients, Inc. engages in operating its subsidiaries, Bite Acquisition Corp. (Bite) and Above Food Corp. (Above Food). The Bite is a blank check company that affects a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Above Food is an ingredient company that provides food products and brands. The company was founded by Lionel Kambeitz on April 18, 2023 and is headquartered in Regina, Canada.

Above Food Ingredients Inc.

ABVE is surging as investors anticipate news related to a merger potentially backed by substantial gold assets and involvement from a Dubai royal family member. The stock's breach of the $5 level is fueling excitement, with community members speculating about a significant short squeeze and a potential run to much higher price levels. Discussions also highlight potential institutional investment and the implications of tokenizing real-world assets.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

Recursion Pharmaceuticals Inc

RXRX is trending due to community discussion around a potential short squeeze, high short interest, and unusual options activity. Optimism surrounds the company's AI-driven drug discovery platform and potential catalysts, while some express concern over cash burn. Investors are closely watching for news and potential partnerships that could drive the stock higher.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending as investors discuss its potential for a short squeeze and await further data, particularly regarding CAN-3110. Community talking points include speculation about upcoming news, potential partnerships, and the company's valuation relative to its pipeline. Some traders express bullish sentiment, while others remain cautious, citing past performance and concerns about management.

American Rebel Holdings, Inc. engages in the design and marketing of branded safes, and personal security and self-defense products. It also designs and manufactures branded apparel and accessories. The company was founded on December 15, 2014 and is headquartered in Brentwood, TN.

American Rebel Holdings Inc

American Rebel Holdings ($AREB) is trending amidst discussions around trading halts, potential breakout points, and the stock's history of multi-day runs. Community members are actively debating its short-squeeze potential and consolidation patterns, with some pointing to a possible 'squirt' to higher levels. Additionally, the buzz around recent biotech releases is contributing to the heightened interest in $AREB.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET is trending due to a recent $75 million investment aimed at accelerating growth in AI connectivity solutions, fueling speculation about the institutional investor behind the deal. Community members are actively discussing the potential impact on the stock price, POET's strategic position in the AI hardware ecosystem, and potential M&A opportunities. Partnerships and the potential to address bottlenecks in AI data centers are also key discussion points.

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.

Xenetic Biosciences Inc

XBIO is trending due to a significant surge, with community members speculating about potential partnerships and pipeline advancements as catalysts. Bullish sentiment is high as traders discuss revenue growth and potential for further gains, while shorts are actively trying to suppress the stock. Some traders are also noting that this might be another short squeeze opportunity.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as traders debate whether the market is overvalued, with some pointing to gold's surge as a warning sign. Community members are discussing the potential impact of the government shutdown and upcoming Fed minutes, while others highlight AI's influence. Bullish sentiment remains strong, as many believe the market will continue its upward trend, while bears warn of an impending correction.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

SPDR Gold Shares ETF ($GLD) is trending amid rising gold prices, fueled by geopolitical tensions and a weakening dollar, which has some analysts predicting further gains. Community members are debating whether gold's surge indicates a broader economic downturn and whether it remains a safe haven asset given its correlation with equities. Discussions also include perspectives on inflation, potential government actions, and historical comparisons to previous market conditions.

AlphaTON Capital Corp. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.

AlphaTON Capital Corp.

AlphaTON Capital Corp. is trending amid discussions about its strategy to merge digital assets with oncology, specifically exploring tokenization for its mesothelioma treatment program. Community members are debating the potential of this move, with some highlighting the company's low float and others cautioning about pump-and-dump schemes. The stock's volatile price action and connection to the TON blockchain and Telegram ecosystem are also key talking points.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Investors Undervaluing Nutrien (NTR) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

New Strong Buy Stocks for October 8th

NTR, CDE, LNZA, AMCX and AVO have been added to the Zacks Rank #1 (Strong Buy) List on October 8, 2025.

Best Income Stocks to Buy for October 8th

STRW, NTR and TSCDY made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 8, 2025.

MOS Gains From Healthy Fertilizer Demand and Cost-Cutting Actions

Mosaic is riding strong fertilizer demand, higher phosphate and potash prices and cost-cutting moves to boost profitability and growth.

NTR's $200M Cost-Saving Drive: Can Expense Cuts Unlock Margin Upside?

Nutrien targets $200M in 2025 cost savings, with Retail and SG&A cuts set to lift margins and free cash flow.

Intrepid Potash (IPI) Soars 8.4%: Is Further Upside Left in the Stock?

Intrepid Potash (IPI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Will Mosaic's Cost-Cutting Momentum Fuel Stronger Margins Ahead? 

MOS targets $250M in cost cuts by 2026, with gains already boosting Fertilizantes EBITDA and margins.

MOS vs. NTR: Which Fertilizer Giant is the Better Pick Now?

Mosaic and Nutrien are riding strong fertilizer demand, cost cuts and capacity growth as farmers benefit from favorable economics.

NTR's Potash Volumes Hit Record High: Can Demand Keep Driving Growth?

Nutrien posts record potash sales and lifts 2025 volume guidance on strong global demand and favorable affordability trends.

Nutrien's Cash Flow Strength: Can Strategic Moves Fuel More Growth?

Nutrien's strong cash flows, strategic asset sales and higher prices position it to sustain growth in the second half.

Nutrien Ltd. is a crop nutrient company, which engages in the production and distribution of products for agricultural, industrial, and feed customer. It operates through the following segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seed, and merchandise. The Potash, Nitrogen, and Phosphate segments produces differentiated chemical nutrient contained in each products. The company was founded on June 2, 2017 and is headquartered in Saskatoon, Canada.

Nutrien Ltd

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

NTR
Nutrien Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest NTR News

NTR Nutrien Ltd